Cell Therapeutics Inc. (CTIC) Reports Q1 Loss of $0.20

Cell Therapeutics Inc. (NASDAQ: CTIC) reported Q1 EPS of ($0.20), versus ($0.18) reported last year. Revenue for the quarter came in at $1.4 million, versus $1.1 million reported last year.

For earnings history and earnings-related data on Cell Therapeutics Inc. (CTIC) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c